FR2296429A1 - Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline - Google Patents

Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline

Info

Publication number
FR2296429A1
FR2296429A1 FR7539814A FR7539814A FR2296429A1 FR 2296429 A1 FR2296429 A1 FR 2296429A1 FR 7539814 A FR7539814 A FR 7539814A FR 7539814 A FR7539814 A FR 7539814A FR 2296429 A1 FR2296429 A1 FR 2296429A1
Authority
FR
France
Prior art keywords
gammaglobulin
tolerance
improving
intravenous injection
intravenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7539814A
Other languages
English (en)
French (fr)
Other versions
FR2296429B1 (xx
Inventor
Waldemar Schneider
Dietrich Wolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RATIOPHARMA ANSTALT
Original Assignee
RATIOPHARMA ANSTALT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RATIOPHARMA ANSTALT filed Critical RATIOPHARMA ANSTALT
Publication of FR2296429A1 publication Critical patent/FR2296429A1/fr
Application granted granted Critical
Publication of FR2296429B1 publication Critical patent/FR2296429B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7539814A 1975-01-02 1975-12-26 Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline Granted FR2296429A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (2)

Publication Number Publication Date
FR2296429A1 true FR2296429A1 (fr) 1976-07-30
FR2296429B1 FR2296429B1 (xx) 1978-12-01

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7539814A Granted FR2296429A1 (fr) 1975-01-02 1975-12-26 Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline

Country Status (20)

Country Link
JP (1) JPS5512001B2 (xx)
AT (1) AT344883B (xx)
AU (1) AU505416B2 (xx)
BE (1) BE837211A (xx)
CA (1) CA1058075A (xx)
DD (1) DD121875A5 (xx)
DE (1) DE2500076C3 (xx)
DK (1) DK144679C (xx)
EG (1) EG11987A (xx)
ES (1) ES443982A1 (xx)
FR (1) FR2296429A1 (xx)
GB (1) GB1495159A (xx)
IE (1) IE43449B1 (xx)
IL (1) IL48766A (xx)
IN (1) IN143525B (xx)
NL (1) NL179824C (xx)
PL (1) PL99599B1 (xx)
SE (1) SE437470B (xx)
SU (1) SU576898A3 (xx)
ZA (1) ZA758050B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122558A2 (en) * 1983-04-06 1984-10-24 Armour Pharmaceutical Company Improved composition of intravenous immune globulin
WO2000048637A1 (de) * 1999-02-21 2000-08-24 B. Braun Melsungen Ag Schmerzfreie und gewebeschonende injektion von arzneimitteln

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
DE3271181D1 (en) * 1982-02-08 1986-06-19 Schweiz Serum & Impfinst Intravenously administrable human immunoglobuline and process for its preparation
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US8497072B2 (en) 2005-11-30 2013-07-30 Abbott Laboratories Amyloid-beta globulomer antibodies
PL2289909T3 (pl) 2005-11-30 2015-04-30 Abbvie Inc Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
WO2008104386A2 (en) 2007-02-27 2008-09-04 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US8987419B2 (en) 2010-04-15 2015-03-24 AbbVie Deutschland GmbH & Co. KG Amyloid-beta binding proteins
CA2808187A1 (en) 2010-08-14 2012-02-23 Abbvie Inc. Amyloid-beta binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (xx) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (xx) * 1973-01-13 1974-09-25

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BERICHT DER 9. TAGUNG DER DEUTSCHEN GESELLSCHAFT FUR BLUTTRANSFUSION IN BRAUNSCHWEIG VOM 26-29 OCTOBER 1960 *
DEUTSCHE MED. WOCHENSCHRIFT 87EME ANNEE, NR. 34 1962 PAGES 1643-1650 SCHULTZE ET AL. : UEBER NEUE MOGLICHKEITEN INTRAVENOSER GAMMAGLOBULIN-APPLIKATION *
PAGES 260-269 STAMPFLI ET AL. : ZUR THERAPEUTISCHEN VERWENDUNG VON GAMMAGLOBULIN BEI BAKTERIELLEN INFEKTIONEN.) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122558A2 (en) * 1983-04-06 1984-10-24 Armour Pharmaceutical Company Improved composition of intravenous immune globulin
EP0122558A3 (en) * 1983-04-06 1985-06-12 Armour Pharmaceutical Company Improved composition of intravenous immune globulin
WO2000048637A1 (de) * 1999-02-21 2000-08-24 B. Braun Melsungen Ag Schmerzfreie und gewebeschonende injektion von arzneimitteln

Also Published As

Publication number Publication date
AT344883B (de) 1978-08-10
JPS5512001B2 (en) 1980-03-29
DE2500076B2 (de) 1979-02-22
AU8792175A (en) 1977-07-14
ES443982A1 (es) 1977-07-16
ZA758050B (en) 1976-12-29
IL48766A (en) 1979-11-30
GB1495159A (en) 1977-12-14
NL179824C (nl) 1986-11-17
AU505416B2 (en) 1979-11-22
DK144679B (da) 1982-05-10
SE7514388L (sv) 1976-07-05
BE837211A (fr) 1976-06-30
IN143525B (xx) 1977-12-17
EG11987A (en) 1981-12-31
JPS5191321A (en) 1976-08-10
NL7514627A (nl) 1976-07-06
DK144679C (da) 1982-10-11
SU576898A3 (ru) 1977-10-15
FR2296429B1 (xx) 1978-12-01
IE43449B1 (en) 1981-02-25
IL48766A0 (en) 1976-02-29
PL99599B1 (pl) 1978-07-31
DE2500076A1 (de) 1976-07-08
CA1058075A (en) 1979-07-10
IE43449L (en) 1976-07-02
DK584375A (da) 1976-07-03
ATA981675A (de) 1977-12-15
DE2500076C3 (de) 1982-11-18
DD121875A5 (xx) 1976-09-05
NL179824B (nl) 1986-06-16
SE437470B (sv) 1985-03-04

Similar Documents

Publication Publication Date Title
FR2296429A1 (fr) Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline
RO71012A (ro) Procedeu de preparare de alchilen tereftalati oligomeri
BE855192A (fr) Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
FR2328689A1 (fr) Procede de preparation d'acides a-arylpropioniques substitues sur le noyau
FR2318131A1 (fr) Procede de production d'hydrocarbures olefiniques
BE844344A (fr) Procede de cyclisation pour la formation d'un noyau cepheme
LU79846A1 (fr) Procede de production d'une preparation de gamma globuline
RO72349A (ro) Procedeu de preparare a unor derivati de imidazol cu actiune farmacologica
FR2321465A1 (fr) Procede de preparation d'hydrocarbures insatures
FR2313447A1 (fr) Procede de production d'une boisson alcoolique
FR2316040A1 (fr) Procede pour l'usinage par etincelage erosif
FR2351922A1 (fr) Procede pour ameliorer la resistance d'un verre de scellement
BE851151R (fr) Procede pour ameliorer la tolerance a l'injection intraveineuse de gammaglobuline
RO66216A (ro) Procedeu pentru producerea energiei
FR2317760A1 (fr) Procede pour la production d'ampoules a vide
FR2306263A1 (fr) Procede ameliore pour produire de l'urokinase
BE846708A (fr) Procede de production d'un alcane-polyol
RO74667A (ro) Procedeu pentru prepararea unor acizi 7 beta-(d-2-amino-2-(alchilsulfonilaminofenil)-acetilamino)-3-alcoxi-3-cefem-4-carboxilici
FR2299869A1 (fr) Procede de preparation d'acides (
FR2329658A1 (fr) Nouveau procede de preparation d'imidazoles substitues
BE865480A (fr) Procede pour la preparation d'acides naphtylaminohydroxysulfoniques
PT64691B (fr) Procede pour la preparation d'acides 6,11-di-hydro-11-oxo-dibenz /b,e/ oxepin-alcanoiques
BE871961A (fr) Procede ameliore pour la production d'alkylene-glycols
FR2352879A1 (fr) Procede pour la production d'
FR2317290A1 (fr) Procede pour la preparation de 5-cyanopyridones-(6)

Legal Events

Date Code Title Description
TP Transmission of property